NCCN is a not-for-profit alliance of 33 leading cancer centers devoted to patient care, research, and education, is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so that patients can live better lives. NCCN offers a number of programs to give clinicians access to tools and knowledge that can help guide decision-making in the management of cancer.
Everolimus plus lanreotide demonstrated an improved PFS compared with everolimus monotherapy in gastroenteropancreatic neuroendocrine tumors.
At a meeting of the DNC, the party seemed to be at pains to demonstrate that it learned nothing from its 2024 defeat. February 02,…
Preliminary data show that AVA6000 led to robust and clinically meaningful tumor shrinkage in patients with salivary gland cancer.
Maria is more than a patient advocate she is a guardian of comfort and a champion of care
An abstract is unavailable.
During a live event, Kathryn E. Beckermann, MD, PhD, discussed the treatment of RCC with insights from a recent trial on sequencing targeted therapies.
First-line IMM-1-104 plus chemotherapy produced responses and disease control in patients with pancreatic cancer.
Moffitt is taking lung screenings on the road with our new mobile low-dose CT scan, ensuring easy access for eligible individuals in Florida.
It can be difficult to stay active, especially when you aren’t feeling your best. Here, our experts share seven tips for balancing activity and rest…
The Howard Hughes Medical Institute has named Fred Hutch Cancer Center postdoctoral researcher Grant King, PhD, a Hanna H. Gray Fellow — investing up to…
